跳至主要内容
临床试验/IRCT2013012412256N1
IRCT2013012412256N1已完成2 期

Evaluation the effect of Clopidogrel in prevention of access graft thrombosis in upper extrimity in patients undergoing hemodialysis in Emam Reza’s Hospital - Kermanshah,2012-2013

Kermanshah Univesity of Medical sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Inclusion criterion: patients with end-stage renal failure who need to vascular access graft placement in upper extremity for hemodialysis.
  • Exclusion criteria: pationts with advanced malignancies and hyper coagolation states; pationts with a history of venous access thrombosis; thrombocytopenia (<100000/ml); thrombpcytosis (>450000/ml); erythrocytosis (hematocrite>55%); patients who receiving warfarin, aspirin or other salicylates, dipyridamole,sulfinpyrazone and ticlopidine or other conditions that anti platelet drugs are contraindicated.

排除标准

  • 未提供

研究者

发起方
Kermanshah Univesity of Medical sciences

相似试验

The effect of clopidogrel in prevention of access... | 临床试验